Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. U.S. Cancer Statistics Working Group. U.S. cancer statistics data visualizations tool, based on 2021 submission data (1999–2019): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. 2022. www.cdc.gov/cancer/dataviz. Accessed 13 July 2022
2. Gogate A, Wheeler SB, Reeder-Hayes KE, Ekwueme DU, Fairley TL, Drier S et al (2021) Projecting the prevalence and costs of metastatic breast cancer from 2015 through 2030. JNCI Cancer Spectrum 5(4):pkab063
3. National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology: breast cancer. Version 4 [Internet]. 2017 [cited 2022 June 26]. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed 13 July 2022.
4. Rugo HS, Rumble RB, Macrae E, Barton DL, Connolly HK, Dickler MN et al (2016) Endocrine therapy for hormone receptor-positive metastatic breast cancer: American society of clinical oncology guideline. J Clin Oncol 34(25):3069–3103
5. Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E (2012) ESMO guidelines working group locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(7):vii11-9
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献